Biočina Bojan, Petričević Mate, Belina Dražen, Gašparović Hrvoje, Svetina Lucija, Konosić Sanja, White Alexandra, Ivančan Višnja, Kopjar Tomislav, Miličić Davor
Bojan Biočina, Department of Cardiac Surgery, University Hospital Center Zagreb, University of Zagreb School of Medicine,
Croat Med J. 2014 Dec;55(6):600-8. doi: 10.3325/cmj.2014.55.600.
To describe our experience in the clinical application of extracorporeal life support (ECLS) and analyze whether ECLS leads to acceptable clinical outcomes in patients with cardiac failure.
Data from clinical database of University Hospital Center Zagreb, Croatia, on 75 patients undergoing ECLS support from 2009 to 2014 due to cardiac failure were retrospectively analyzed. Outcomes were defined as procedural and clinical outcomes. ECLS as a primary procedure and ECLS as a postcardiotomy procedure due to inability to wean from cardiopulmonary bypass were analyzed.
ECLS was used in 75 adult patients, and in 24 (32%) of those procedural success was noted. ECLS was implemented as a primary procedure in 36 patients and as a postcardiotomy procedure in 39 patients. Nine out of 39 (23.08%) patients had postcardiotomy ECLS after heart transplantation. Bleeding complications occurred in 30 (40%) patients, both in primary (11/36 patients) and postcardiotomy group (19/39 patients). ECLS was established by peripheral approach in 46 patients and by central cannulation in 27 patients. In 2 patients, combined cannulation was performed, with an inflow cannula placed into the right atrium and an outflow cannula placed into the femoral artery. Eleven patients treated with peripheral approach had ischemic complications.
ECLS is a useful tool in the treatment of patients with refractory cardiac failure and its results are encouraging in patients who otherwise have an unfavorable prognosis. Patient outcomes may be further improved by technological advances, more clinical experience in application of the technique, careful patient selection, and multidisciplinary approach in patient management.
描述我们在体外生命支持(ECLS)临床应用中的经验,并分析ECLS是否能为心力衰竭患者带来可接受的临床结局。
回顾性分析克罗地亚萨格勒布大学医院中心临床数据库中2009年至2014年因心力衰竭接受ECLS支持的75例患者的数据。结局定义为手术结局和临床结局。分析了作为主要手术的ECLS以及因无法脱离体外循环而作为心脏切开术后手术的ECLS。
75例成年患者使用了ECLS,其中24例(32%)手术成功。36例患者将ECLS作为主要手术实施,39例患者将其作为心脏切开术后手术实施。39例患者中有9例(23.08%)在心脏移植后进行了心脏切开术后ECLS。30例(40%)患者出现出血并发症,主要手术组(11/36例患者)和心脏切开术后组(19/39例患者)均有发生。46例患者通过外周途径建立ECLS,27例患者通过中心插管建立。2例患者进行了联合插管,将流入插管置于右心房,流出插管置于股动脉。11例接受外周途径治疗的患者出现缺血并发症。
ECLS是治疗难治性心力衰竭患者的有用工具,其结果对于预后不佳的患者令人鼓舞。通过技术进步、该技术应用方面更多的临床经验、仔细的患者选择以及患者管理中的多学科方法,患者结局可能会进一步改善。